Abstract P3-11-12: Biomarker phase neo-DDRD trial: Predicting response to neoadjuvant chemotherapy (NAC) in early breast cancer using the DNA damage repair deficiency (DDRD) assay
EE Parkes, CR James, T Lioe, S Walker, KI Savage, K Lowry, L Knight, A McCavigan, G Logan, J Hurwitz, SJ Kirk, P Harkin, RD Kennedy, SA McIntosh
Research output: Contribution to journal › Meeting abstract › peer-review
Fingerprint
Dive into the research topics of 'Abstract P3-11-12: Biomarker phase neo-DDRD trial: Predicting response to neoadjuvant chemotherapy (NAC) in early breast cancer using the DNA damage repair deficiency (DDRD) assay'. Together they form a unique fingerprint.